NEW YORK (Reuters Health) – New research suggests concerns over the concurrent use of bedaquiline and delamanid in patients with drug-resistant tuberculosis were unwarranted. “Prior
Read more
Home ยป
NEW YORK (Reuters Health) – New research suggests concerns over the concurrent use of bedaquiline and delamanid in patients with drug-resistant tuberculosis were unwarranted. “Prior
Read moreNOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-LANSOPRAZOLE ODT Lansoprazole Consumer Medicine Information What is in this leaflet This
Read more